Open access · US-GOV via ClinicalTrials.gov Clinical trial

Resilience Enhancement Utilizing an Electronic Frailty Index-Directed Care Pathway for Older Adults Receiving Chemotherapy (RESILIENCE-e): A Prospective Single-Arm Interventional Study

Authors not listed

Wake Forest University Health Sciences · 2026

Dysbiosis Human Randomized controlled trial

Abstract

The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their individual needs.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-14 MST

Cite this

APA

Anonymous. (2026). Resilience Enhancement Utilizing an Electronic Frailty Index-Directed Care Pathway for Older Adults Receiving Chemotherapy (RESILIENCE-e): A Prospective Single-Arm Interventional Study. <em>Wake Forest University Health Sciences</em>. https://clinicaltrials.gov/study/NCT07175376

Vancouver

Anonymous. Resilience Enhancement Utilizing an Electronic Frailty Index-Directed Care Pathway for Older Adults Receiving Chemotherapy (RESILIENCE-e): A Prospective Single-Arm Interventional Study. Wake Forest University Health Sciences. 2026.

BibTeX

@misc{anon2026Resili, title = {Resilience Enhancement Utilizing an Electronic Frailty Index-Directed Care Pathway for Older Adults Receiving Chemotherapy (RESILIENCE-e): A Prospective Single-Arm Interventional Study}, author = {Anonymous}, journal = {Wake Forest University Health Sciences}, year = {2026}, }